Kazakh startup CerebraAI for medical diagnostics was presented at an exhibition in Shanghai, El.kz reports with reference to the press service of the Government of Kazakhstan.
The Kazakh company Cerebra AI, specializing in artificial intelligence (AI) for diagnosing strokes continues to expand in foreign markets.
More than 700 neurosurgeons and neurologists actively use the software in 47 Kazakhstani stroke centers. The technologies have also been introduced in hospitals in Uzbekistan and Saudi Arabia. The company's priority is to deepen cooperation in the field of collection and processing of medical data.
"China is a strategically important market for us. We came here to meet local companies, demonstrate our product and discuss cooperation opportunities. China is a leader in the field of technology development, and we are confident that here we will be able to exchange experience and expand the horizons of our business," said Arman Ospanov, Director of Cerebra AI.